GLP-1 RAs Linked to Doubled Risk for Macular Degeneration

Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for neovascular age-related macular degeneration in a large Canadian study.
Medscape Medical News